Rui Liu

Dr. Rui Liu


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2022 in Translational Vision Science & Technology
Verified
Journal Article
Open access
PDF file
GLGang Luo
Gang Luo
CLChen-Yuan Lee
Chen-Yuan Lee
PSPrerana Shivshanker
Prerana Shivshanker
WCWenbo Cheng
Wenbo Cheng
JWJamie Wang
Jamie Wang
RLRui Liu
Rui Liu
Purpose: The purpose of this study was to evaluate the potential feasibility of using a smartphone app in myopia screening. Methods: The app estimates myopic refractive error by measuring the far point distance for reading three 20/20 Tumbling E letters. In total, 113 myopic subjects with astigmatism no greater than −1.75 diopters (D) were enrolled from 5 sites. The mean age was 22 ± 8.5 years. The app measurement was compared with noncycloplegic subjective refraction measurement or autorefractor if subjective refraction was not available. In addition, 22 subjects were tested with the app for repeatability. Results: For 201 eyes included, the range of spherical equivalent refraction error was 0 to −10.2 D. The app measurement and clinical measurement was highly correlated (Pearson R = 0.91, P < 0.001). There was a small bias (0.17 D) in the app measurement overall, and it was significantly different across the 5 sites due to different age of subjects enrolled at those sites (P = 0.001) – young adults in their 20s were underestimated the most by 0.49 D, whereas children were overestimated by 0.29 D. The mean absolute deviation of the app measurement was 0.65 D. The repeatability of multiple testing in terms of 95% limit of agreement was ±0.61 D. Conclusions: Overall, the app measurement is consistent with clinical measurement performed by vision care professionals. The repeatability is comparable with that of some autorefractors. Age-associated human factors may influence the app measurement. Translational Relevance: The app could be potentially used as a mass screening tool for myopia.

1 May 2019 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
TTTian Tian
Tian Tian
LZLeilei Zou
Leilei Zou
SWSujia Wu
Sujia Wu
HLHong Liu
Hong Liu
RLRui Liu
Rui Liu
Purpose: Environmental light plays an important role in the process of emmetropization. This study investigated how the retina integrates wavelength and temporal signals to regulate eye emmetropization. Methods: Guinea pigs (n = 220) were randomly divided into 11 groups (n = 20/group) that received different environmental lighting (12:12 light cycle) for 8 weeks: white, green, or blue light at steady, 0.5 or 20 Hz. White-steady group was repeated for each wavelength. Refraction, axial length, and corneal curvature were measured using streak retinoscopy, A-scan ultrasonography, and keratometry, respectively, every 2 weeks. Results: (1) In white light, the white-0.5 Hz group was more myopic than the white-steady group or the white-20 Hz group (both P < 0.0001), with a longer axial length (both P < 0.0001). White-20 Hz did not significantly differ from white-steady. (2) At low temporal frequencies (0 and 0.5 Hz), green-steady (P = 0.0008) and green-0.5 Hz (P < 0.0001), were more myopic than the white-steady group, with longer axial lengths (both P < 0.0001). No significant difference was found between green-0.5 Hz and green-steady. Blue-steady and blue-0.5 Hz were more hyperopic than white-steady (both P < 0.0001), with shorter axial lengths (both P < 0.0001). Blue-0.5 Hz showed no significant difference from blue-steady. (3) At high temporal frequencies (20 Hz), green-20 Hz, was more hyperopic than green-steady or green-0.5 Hz (both P < 0.0001) and had a shorter axial length (both P < 0.0001). Green-20 Hz showed a 1.10 D hyperopic shift compared to green-steady. Blue-20 Hz was less hyperopic than blue-steady (P < 0.0001) or blue-0.5 Hz (P = 0.0012), with a longer axial length (both P < 0.0001). Blue-20 Hz showed a 1.18 D myopic shift compared to blue-steady. Conclusions: Eyes use both wavelength and temporal frequency of light to regulate emmetropization. Their interactions provide different cues to control eye growth. At low temporal frequencies, the eye can use wavelength defocus to guide eye growth. This signal is weakened at high temporal frequencies.

2 September 2021 in Investigative Ophthalmology & Visual Science
Verified
Journal Article
Open access
PDF file
TTTian Tian
Tian Tian
LZLeilei Zou
Leilei Zou
SWShu Wang
Shu Wang
RLRui Liu
Rui Liu
HLHong Liu
Hong Liu
Purpose: Wavelength and temporal frequency have been found to influence refractive development. This study investigated whether retinal dopamine (DA) plays a role in these processes. Methods: Guinea pigs were randomly divided into nine groups that received different lighting conditions for 4 weeks, as follows: white, green, or blue light at 0, 0.5, or 20.0 Hz. Refractions and axial lengths were measured using streak retinoscopy and A-scan ultrasound imaging. DA and its metabolites were measured by high-pressure liquid chromatography-electrochemical detection. Results: At 0 Hz, green and blue light produced myopic and hyperopic shifts compared with that of white light. At 0.5 Hz, no significant changes were observed compared with those of green or blue light at 0 Hz, whereas white light at 0.5 Hz induced a myopic shift compared with white light at 0 or 20 Hz. At 20 Hz, green and blue light acted like white light. Among all levels of DA and its metabolites, only vitreous 3, 4-dihydroxyphenylacetic acid (DOPAC) levels and retinal DOPAC/DA ratios were dependent on wavelength, frequency, and their interaction. Specifically, retinal DOPAC/DA ratios were positively correlated with refractions in white and green light conditions. However, blue light (0, 0.5, and 20.0 Hz) produced hyperopic shifts but decreased vitreous DOPAC levels and retinal DOPAC/DA ratios. Conclusions: The retinal DOPAC/DA ratio, indicating the metabolic efficiency of DA, is correlated with ocular growth. It may underlie myopic shifts from light exposure with a long wavelength and low temporal frequency. However, different biochemical pathways may contribute to the hyperopic shifts from short wavelength light.

23 November 2021 in Seminars in Ophthalmology
Verified
Journal Article
Closed access
LZLeilei Zou
Leilei Zou
TTTian Tian
Tian Tian
TWTamara Wygnanski-Jaffe
Tamara Wygnanski-Jaffe
OYOren Yehezkel
Oren Yehezkel
SWShu Wang
Shu Wang
RLRui Liu
Rui Liu
To assess the effectiveness of an eye-tracking-based test (ETBT) to measure eye deviation angle vs. a manual prism alternating cover test (PACT) in children with strabismus.The prospective, masked,...

1 September 2021 in JAMA Ophthalmology
Verified
Journal Article
Closed access
PDF file
SWShu Wang
Shu Wang
WWWen Wen
Wen Wen
WZWenqing Zhu
Wenqing Zhu
YLYan Liu
Yan Liu
LZLeilei Zou
Leilei Zou
HLHong Liu
Hong Liu
Importance Patching is often less effective for severe amblyopia because of poor adherence. For the treatment of severe amblyopia, although combined atropine and patching therapy (CAPT) has been found to be efficacious, it is currently unknown whether CAPT is more efficacious than patching alone. Objective To compare the efficacy of CAPT vs patching alone in children aged 3 to 12 years with severe amblyopia. Design, Setting, and Participants This single-center randomized clinical trial was conducted from November 2018 to May 2020. The visual acuity (VA) examiner was masked to the treatment groups. The follow-up visits were at 3 months and 6 months. Participants aged 3 to 12 years with severe amblyopia (20/100 to 20/500) resulting from strabismus, anisometropia, or both were randomly assigned to CAPT or patching therapy. Interventions CAPT or patching alone for 6 months. Main Outcomes and Measures Change of the amblyopic eye VA from baseline to 6 months. Results Among 108 participants, the mean (SD) age was 5.2 (1.8) years, and 54 (50%) were female. Overall, 53 participants (49%) were randomized to CAPT and 55 (51%) were randomized to patching therapy. At baseline, the mean (SD) amblyopic eye VA was 0.95 (0.22) logMAR (approximately 20/200 [2.2 lines]). At 6 months, the CAPT group’s mean improvement in amblyopic eye VA was 0.72 logMAR (7.2 lines) compared with 0.58 logMAR (5.8 lines) in the patching alone group (difference, 0.14 logMAR [1.4 lines] greater in the CAPT group; 95% CI, 0.05-0.22 logMAR [0.5-2.2 lines];P = .002). The amblyopic eye VA improvement in the CAPT group also was greater than that in the patching alone group at 3 months (difference in the means, 0.13 logMAR [1.3 lines]; 95% CI, 0.04-0.22 logMAR [0.4-2.2 lines];P = .004). No participants were withdrawn because of adverse effects. Conclusions and Relevance CAPT resulted in more mean improvement of amblyopic eye VA than patching alone among participants enrolled in this trial, although the clinical relevance of this relatively small VA difference cannot be determined from this trial. Trial Registration Chinese Clinical Trial Registry Identifier:ChiCTR1800018663